Table II.

The most common factors clinicians identified for patients with moderate-to-severe atopic dermatitis or psoriasis in discontinuing systemic therapy (N = 265)^∗

Patient treatment challenge group	No. of respondents (%)
No symptom improvement	100 (37.7)
Insurance declined	84 (31.7)
Patient financial burden	39 (14.7)
Side effects	33 (12.5)
Other	9 (3.4)

^∗Respondents were asked to select their top reason (a single response permitted).